Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,500
Closed -$256K 1286
2020
Q4
$256K Buy
+4,500
New +$246K ﹤0.01% 1152
2016
Q3
Sell
-13,050
Closed -$421K 1290
2016
Q2
$421K Sell
13,050
-700
-5% -$24.2K ﹤0.01% 1042
2016
Q1
$552K Sell
13,750
-65,300
-83% -$2.56M ﹤0.01% 977
2015
Q4
$3.37M Sell
79,050
-300
-0.4% -$14K 0.01% 663
2015
Q3
$3.05M Buy
79,350
+9,700
+14% +$383K 0.01% 689
2015
Q2
$2.93M Buy
69,650
+4,600
+7% +$193K 0.01% 709
2015
Q1
$2.74M Buy
+65,050
New +$2.47M 0.01% 725

Other funds holding MATX

Axa's MATX Position: Q1 2021 in Review

Axa sold out of Matsons (MATX) in Q1 2021, closing a stake of 4,500 shares — an estimated $256K sold.

Axa first reported a position in MATX in Q1 2015 and held it in 7 quarters. The position peaked at $3.37M in Q4 2015. 231 funds tracked by Wall St. Rank hold MATX as of Q1 2021.

  • Axa reported no remaining Matsons position as of Q1 2021 after selling out during the quarter.
  • Axa sold 4,500 Matsons shares in Q1 2021, an estimated $256K.
  • Axa first reported a position in Matsons in Q1 2015 and held it in 7 quarters.
  • Axa's Matsons position peaked at $3.37M in Q4 2015.
  • 231 funds tracked by Wall St. Rank held Matsons as of Q1 2021.

Based on Axa's 13F filing for Q1 2021, filed 14 May 2021.